申请人:Dropinski F. James
公开号:US20080039514A1
公开(公告)日:2008-02-14
A class of compounds having Formula I and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of developing conditions and sequelae that are associated with these diseases, such as atherosclerosis.
具有I式和其药物可接受的盐的化合物类别,可用作治疗化合物,特别是用于治疗高脂血症、高胆固醇血症、脂质代谢异常和其他脂质紊乱,并延缓或降低与这些疾病相关的病症和后遗症的发生风险,例如动脉粥样硬化。